Samar A. Nasser

发表

Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.

R. Califf, K. Ferdinand, M. Fiuzat, 2017, Journal of the American College of Cardiology.

Dietary Approaches to Hypertension: Dietary Sodium and the DASH Diet for Cardiovascular Health

K. Ferdinand, Samar A. Nasser, D. Ferdinand, 2021, Contemporary Cardiology.

Hypertension in special populations.

J. Flack, V. Mehra, Samar A. Nasser, 2003, Current problems in cardiology.

Hypertension in special populations.

J. Flack, V. Mehra, Samar A. Nasser, 2002, Cardiology clinics.

Underuse of antihypertensive therapies in at-risk populations

J. Flack, Samar A. Nasser, S. O’Connor, 2008 .

Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence

K. Ferdinand, K. Yadav, F. Senatore, 2017, Journal of clinical hypertension.

Community‐Based Approaches to Prevention and Management of Hypertension and Cardiovascular Disease

K. Ferdinand, Samar A. Nasser, D. Ferdinand, 2012, Journal of clinical hypertension.

Hypertension in Racial and Ethnic Minorities

J. Flack, Samar A. Nasser, S. O’Connor, 2007 .

Chapter 39 – Hypertension in African Americans

T. Shafi, J. Flack, E. Crook, 2007 .

African-American COVID-19 Mortality

K. Ferdinand, Samar A. Nasser, 2020, Journal of the American College of Cardiology.

Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial Discrimination.

K. Ferdinand, Samar A. Nasser, 2017, Mayo Clinic proceedings.

Contemporary concepts in access to healthcare: Identification and elimination of disparities in care of minority patients.

F. Senatore, Samar A. Nasser, 2019, Progress in cardiovascular diseases.

Reply: Directly Observed Therapy: A Possible Tool to Tackle Medication Nonadherence in the CVD Epidemic.

K. Ferdinand, F. Senatore, Samar A. Nasser, 2017, Journal of the American College of Cardiology.

Cardiovascular Disease in Minorities: Unique Considerations: Hypertension in African and Hispanic Americans

K. Ferdinand, K. Jamerson, Samar A. Nasser, 2021, Contemporary Cardiology.

Working Agenda for Black Mothers

K. Watson, K. Ferdinand, E. Ofili, 2021, Circulation. Cardiovascular quality and outcomes.

Community Outreach to African-Americans: Implementations for Controlling Hypertension

K. Ferdinand, Samar A. Nasser, 2018, Current Hypertension Reports.

Cardiovascular Disease and Diabetic Kidney Disease

K. Ferdinand, Samar A. Nasser, Ayan Ali, 2022, Diabetes and Kidney Disease.

Benefits of once-daily therapies in the treatment of hypertension

J. Flack, Samar A. Nasser, 2011, Vascular health and risk management.

Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.

T. Shafi, J. Flack, E. Crook, 2003, Journal of the American Society of Nephrology : JASN.

PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)

K. Ferdinand, Samar A. Nasser, 2015, Cardiovascular Drugs and Therapy.

Unmasking Racial/Ethnic Disparities in Cardiovascular Disease: Nutritional, Socioeconomic, Cultural, and Health-Care-Related Contributions

J. Flack, Samar A. Nasser, S. O’Connor, 2009 .

Improved Understanding and Innovative Approaches for an Aging Dilemma: Resistant Hypertension in Women with Existing Vascular Disease

K. Ferdinand, Samar A. Nasser, 2012, Current Cardiovascular Risk Reports.

Circulation: Cardiovascular Quality and Outcomes

K. Ferdinand, K. Watson, E. Ofili, 2020, Circulation: Cardiovascular Quality and Outcomes.

Determinants of Blood Pressure Response to Quinapril in Black and White Hypertensive Patients: The Quinapril Titration Interval Management Evaluation Trial

T. Shafi, E. Saunders, J. Flack, 2004, Hypertension.

Cardiorenal Metabolic Syndrome and Cardiometabolic Risks in Minority Populations

Priscilla E. Pemu, K. Ferdinand, J. Foody, 2013, Cardiorenal Medicine.

Therapy of Hypertension in African Americans

P. Levy, J. Flack, Samar A. Nasser, 2011, American Journal of Cardiovascular Drugs.

African American COVID-19 Mortality: A Sentinel Event

K. Ferdinand, Samar A. Nasser, 2020 .

Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

S. Nesbitt, G. Bakris, K. Ferdinand, 2010, Hypertension.

EFFECT OF LOWER BLOOD PRESSURE GOALS ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH SUBCLINICAL HYPERTENSIVE HEART DISEASE.

A. Brodsky, A. Brody, P. Levy, 2020, American journal of hypertension.

Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations.

K. Ferdinand, J. Flack, Samar A. Nasser, 2010, Cardiology clinics.

Hypertension Management in the Elderly

K. Ferdinand, Samar A. Nasser, 2018, Management of Hypertension.

Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement

M. Gulati, K. Ferdinand, E. Michos, 2021, American journal of preventive cardiology.

Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost‐effectiveness Analysis

A. Brody, P. Levy, M. Twiner, 2017, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

A. Brody, P. Levy, J. Flack, 2016, Journal of the American Society of Hypertension : JASH.

Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?

J. Flack, Samar A. Nasser, Xuefeng Liu, 2008, Current hypertension reports.

A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension

K. Ferdinand, Samar A. Nasser, 2013, American Journal of Cardiovascular Drugs.

Management of Essential Hypertension.

K. Ferdinand, Samar A. Nasser, 2017, Cardiology clinics.

Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease.

A. Brody, P. Levy, J. Flack, 2014, Journal of the American Society of Hypertension : JASH.

Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus

K. Ferdinand, Samar A. Nasser, 2015, Current medical research and opinion.

Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy

Amanda Dudley, Xuefeng Liu, John M Flack, 2007, Vascular health and risk management.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.

John M Flack, J. Flack, Samar A. Nasser, 2003 .

Epidemiology of Hypertension and Cardiovascular Disease in African Americans

K. Ferdinand, J. Flack, Samar A. Nasser, 2003, Journal of clinical hypertension.

Effect of dimethylarginine dimethylaminohydrolase in the development of salt sensitivity

Samar A. Nasser, 2011 .

Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient

K. Ferdinand, Samar A. Nasser, 2015, Current Hypertension Reports.

Initial treatment of hypertension with aliskiren and amlodipine combination gives 6.5 mm Hg greater reduction in systolic BP than does either monotherapy

P. Levy, J. Flack, Samar A. Nasser, 2011, Evidence Based Medicine.

J. Flack, Samar A. Nasser, 2003, Current hypertension reports.

Addressing Cardiovascular Disparities in Racial/Ethnic Populations: The Blood Pressure-Lowering Effects of SGLT2 Inhibitors

K. Ferdinand, Samar A. Nasser, Neha Arora, 2022, Reviews in cardiovascular medicine.